How many stocks are there of Brainsway?
The current number of stocks of Brainsway is 32.28 M undefined.
Brainsway Stocks 2024
Brainsway Stocks
32.28 M
Brainsway Dividend yield
Ticker
BWAY.TA
ISIN
IL0011007189
WKN
A0NDVW
In 2024, Brainsway had 32.28 M outstanding stocks, a 0% change from the 32.28 M stocks in the previous year.
The Brainsway Stocks history
| YEAR | NUMBER OF STOCKS (undefined USD) |
|---|---|
| 2026e | 32.28 |
| 2025e | 32.28 |
| 2024e | 32.28 |
| 2023 | 32.28 |
| 2022 | 32.98 |
| 2021 | 31.15 |
| 2020 | 22.45 |
| 2019 | 20.51 |
| 2018 | 16.64 |
| 2017 | 14.77 |
| 2016 | 14.51 |
| 2015 | 14.46 |
| 2014 | 14.16 |
| 2013 | 12.87 |
| 2012 | 12.17 |
| 2011 | 11.83 |
| 2010 | 42.58 |
| 2009 | 38.44 |
| 2008 | 35.62 |
| 2007 | 34.98 |
| 2006 | 26.31 |
Brainsway Aktienanalyse
What does Brainsway do?
Brainsway Ltd is a leading provider of non-invasive brain stimulation solutions based in Jerusalem, Israel. The company was founded in 2003 and has since become a major player in the field of neurological disorders. Brainsway's business model includes the development, production, and marketing of innovative brain stimulation solutions. The company's products are based on transcranial magnetic stimulation (TMS), a proven technology for treating neurological disorders. TMS involves generating brain stimulation through a non-invasive method, using gentle magnetic pulses directed at the targeted area of the brain to specifically influence brain activity. The company is divided into three business areas: psychiatry, neurology, and rehabilitation. The psychiatry area includes the treatment of disorders such as depression, obsessive-compulsive disorder, addiction, and schizophrenia. The neurology area, on the other hand, focuses on disorders such as Parkinson's disease, Alzheimer's disease, and epilepsy. The rehabilitation area is used for anatomical rehabilitation and stroke rehabilitation and is the newest product of Brainsway. Each area includes a variety of products tailored to the individual needs of users. One of Brainsway's most well-known products is the Deep TMS Stimulator, which was specifically developed for the treatment of depression. The Deep TMS therapy has been clinically tested and identified as an effective method for treating depression, obsessive-compulsive disorder, and ADHD. The device has already been marketed in over twenty countries. Brainsway is also a leader in the treatment of Parkinson's disease with TMS. Clinical studies have shown that the application of Brainsway TMS in Parkinson's patients reduces symptoms by almost 50%. The benefits of TMS in Parkinson's include improved motor function, increased quality of life, and a reduction in the frequency of falls. The company has established collaborations with major pharmaceutical companies and research institutions. Brainsway works closely with scientific institutions to continuously develop and improve therapies and products. Brainsway Ltd is an innovative company that is a leader in the field of non-invasive brain stimulation. Brainsway's products have proven to be effective in treating a variety of disorders, and the company has a promising future in researching and developing new therapies. Brainsway ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Brainsway's Shares Outstanding
Brainsway's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Brainsway’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Brainsway’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Brainsway’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Brainsway Stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Brainsway are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Brainsway evolved in recent years?
The number of shares of Brainsway has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Brainsway as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Brainsway?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Brainsway pay?
Over the past 12 months, Brainsway paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Brainsway is expected to pay a dividend of 0 USD.
What is the dividend yield of Brainsway?
The current dividend yield of Brainsway is .
When does Brainsway pay dividends?
Brainsway pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Brainsway?
Brainsway paid dividends every year for the past 0 years.
What is the dividend of Brainsway?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Brainsway located?
Brainsway is assigned to the 'Health' sector.
Wann musste ich die Aktien von Brainsway kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Brainsway from 5/31/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/31/2024.
When did Brainsway pay the last dividend?
The last dividend was paid out on 5/31/2024.
What was the dividend of Brainsway in the year 2023?
In the year 2023, Brainsway distributed 0 USD as dividends.
In which currency does Brainsway pay out the dividend?
The dividends of Brainsway are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Brainsway
Our stock analysis for Brainsway Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Brainsway Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
